MDx-Chex® for BC-GP and MDx-Chex® for BC-GN

MDx-Chex for BC-GP and BC-GN are controls designed to evaluate the entire analytical process of the Luminex VERIGENE® BC-GP and BC-GN Panels for sepsis. With MDx-Chex for BC-GP and BC-GN, you can track lot-to-lot performance of the BC-GP and BC-GN assays and reduce the occurrence of incorrect results due to instrument or assay failures.

MDx-Chex for BC-GP and MDx-Chex for BC-GN

MDx-Chex for BC-GP and BC-GN are patient-like full process controls designed to validate the entire analytical process of the Luminex VERIGENE BC-GP and BC-GN Panels, including automated nucleic acid extraction, DNA purification, hybridization of target DNA to the microarray, hybridization of gold nanoparticles to target DNA and silver staining of hybridized probes. MDx-Chex for BC-GP and BC-GN cover all targets tested with Luminex VERIGENE for BC-GP or BC-GN, respectively. Microorganisms are intact, inactivated and…

Show More
MDx-Chex for BC-GN product

Features

  • Patient-like matrix of inactivated microorganisms, blood cells and culture media components
  • Can be directly used on the Luminex VERIGENE system
  • Complete coverage of all BC-GP or BC-GN Panel targets in a single vial
  • Negative controls contain only blood cells and culture media components for a true patient-like negative control

Benefits

  • Challenges and verifies the entire analytical process of the Luminex VERIGENE assays
  • Reduces preanalytical variables such as pipetting errors and cross-contamination
  • Easy to use — simply pipette like a patient sample

Benefits of MDx-Chex for BC-GP and BC-GN over other available controls

Streck

Competitor A

Competitor B

Preanalytical Variables

Sample tracking (via barcode)^

Yes

No

No

Controls technician sample handling

Yes

No

No+

Preanalytical Variables

Lysing

Contains non-infectious intact organisms

Yes

No

Yes

Contains human RBCs and WBCs

Yes

No

No

Lyses all panel organisms

Yes

No

Yes*

Nucleic Acid Isolation and Purification

Yes

No

No

Patient-like sample matrix

Yes

No

No

Inhibitors

RBCs (i.e., hemoglobin)

Yes

No

No

WBCs (i.e., interleukin, human genomic DNA)

Yes

No

No

Culture media chemicals

Yes

No

No

Specificity

All targets present

Yes

Yes**

Yes*

Off target (human gDNA) present

Yes

No

No

Detection

All DNA targets

Yes•

No

Yes*

FDA Class II Clearance

Yes

No

No

+ Requires pooling of multiple components, not part of patient sample testing workflow
* If all panel organisms are pooled
Streck controls contain all DNA targets for the Luminex VERIGENE BC-GP and BC-GN Tests
** When Lyophilized pellets are rehydrated and pooled together
^ Barcode allows the control lot number, expiration date and level to be captured in the software

DescriptionCatalog Number
 
MDx-Chex for BC-GP – 5 Positive control vials & 5 Negative control vials, 5 control events250079
MDx-Chex for BC-GN – 5 Positive control vials & 5 Negative control vials, 5 control events250080

Order MDx-Chex for BC-GP and BC-GN today

New customers

Existing customers

International customers find a distributor

With full-process controls and antibiotic resistance kits, Streck has the products to help you streamline your molecular diagnostics testing, aid antibiotic stewardship and ensure positive patient outcomes.

Streck ARM-D Kits

The latest from the blog

Molecular

New antibiotic fights antimicrobial resistant bacteria

Recent work published in Nature has introduced Zosurabalpin, a new antibiotic effective against Carbapenem-resistant Acinetobacter baumannii (CRAB). D…
Read More
Molecular

2022 HAI Progress Report released by the CDC

When it comes to public health and health care, improvement of patient safety and prevention of adverse events are top priorities for the Centers for …
Read More
Molecular

CDC expands disease surveillance at major U.S. airports

U.S. airports host more than 1 billion visitors each year, and it’s not just people. New and emerging bacteria, viruses and other microbes travel th…
Read More